Glioblastoma vs Astrocytoma: A Patient Guide

If you or a loved one has been diagnosed with an astrocytoma or glioblastoma (GBM), you likely have many questions and worries. This guide will explain the differences between glioblastoma (Grade IV) and other astrocytoma brain tumor grades (like Grade III anaplastic astrocytoma and lower-grade astrocytomas) in clear, patient-friendly language. We’ll cover what the grades mean, how fast the tumors grow, what genetic markers like IDH and MGMT mean, and how all this affects treatment and prognosis. We aim to empower you with knowledge – because understanding your diagnosis can help you and your doctors make the best treatment decisions. 

Common concerns: “Is a Grade III astrocytoma as dangerous as a Grade IV glioblastoma? What does a ‘lower-grade’ tumor mean for my life expectancy? Will my treatment be as aggressive?”

These are all normal questions. In this guide, we’ll answer them with empathy and facts, so you can feel more confident about what lies ahead. Remember, every patient is unique – but learning about general patterns can guide meaningful conversations with your care team. Let’s start by clarifying the basic difference between astrocytomas and glioblastomas. 

Glioblastoma vs. Astrocytoma: What’s the Difference? 

To answer this question, let’s first start with the main cells in the brain. The neurons are the cells that we think of when we talk about brain function. They send the signals. Then there are cells that support and nourish neurons, called glial cells. Glial cells are made up of both Oligodendrocytes and Astrocytes. Astrocytomas are a broad group of tumors, that have one thing in common – they arise from astrocytes – star-shaped support cells in the brain. Glioblastoma is a type of astrocytoma, specifically the most aggressive Grade IV form. When a tumor arises from the glial cells, it is called a glioma. When it specifically arises from the Astrocytes, it is an Astrocytoma! 

The key difference is in tumor grade (aggressiveness) and genetics. A glioblastoma (GBM) is a Grade IV astrocytoma – the highest grade, meaning it grows the fastest and is the most aggressive. In contrast, when doctors say “astrocytoma” on its own, they could mean lower-grade tumors (Grade II or III) which tend to grow more slowly and are less aggressive. Grade I astrocytomas are the most benign. They tend to be well-circumscribed – meaning they do NOT invade normal brain. Grade II-IV gliomas are diffuse – meaning they invade normal brain.  

Historically, gliomas were diagnosed based on microscopic appearance. But we now know that microscopic appearances can be wrong and that the genetic mutations play a key part as well. As of the WHO’s latest classifications (2021), doctors now distinguish them by genetic mutations, including the most impactful one called IDH: 

• Diffuse astrocytomas (Grades II and III) can either be IDH-mutant tumors (they have a mutation in the isocitrate dehydrogenase gene) or IDH-wildtype (they do not have the IDH mutation). This mutation is good news in a way – IDH-mutant tumors generally behave less aggressively and patients tend to live longer than those with IDH-wildtype tumors. So if you have a lower-grade astrocytoma, and it carries an IDH mutation (your doctors will test for this), the prognosis is better. Having said that, Grade II-III astrocytoma that are IDH-wildtype nonetheless have a better prognosis than GBM. Glioblastoma.   

• To qualify as a GBM, the Astrocytoma must be IDH-wildtype (no IDH mutation). These tumors often arise de novo (out of the blue) in older adults and have a different molecular profile and behavior. Glioblastomas grow quickly, invade widely, and have distinct microscopic features like areas of dead cells (necrosis) and abnormal blood vessels that lower-grade astrocytomas usually lack. If there is an IDH mutation, the tumor cannot be called a GBM. It can, however, be a Grade IV, IDH-mutant, Astrocytoma. 

• Sometimes, the astrocytoma may not have all the microscopic features to qualify as a Grade IV. With the new molecular focused classification (since 2021), some of these may still be diagnosed as GBM. Make sure to ask your doctor about TERT promoter mutation, EGFR vIII amplification, and CDKN2A deletion.  

What about Grade III?

Grade III astrocytomas are often called anaplastic astrocytomas (though the latest WHO terminology simply calls them “Grade 3 astrocytoma” without using the word anaplastic). These are high-grade tumors (malignant), but not as aggressive as Grade IV GBM. Think of Grade III as an “intermediate” – more aggressive than Grade II, but usually less so than glioblastoma. If a Grade III astrocytoma has the IDH mutation (which some do), doctors consider it a different entity from an IDH-wildtype GBM or even Grade III Astrocytoma. In practice, though, both Grade III and IV will be treated as malignant brain cancers, requiring prompt, aggressive therapy, whereas Grade II tumors might be managed more conservatively in some cases. 

In short, “glioblastoma vs. astrocytoma” largely comes down to Grade IV vs. lower grades and IDH status. GBM is the fastest-growing, most malignant form of astrocytoma (usually IDH-wildtype), whereas lower-grade astrocytomas grow slower and often carry an IDH mutation that gives them a different (better) prognosis. Now let’s break down what “grade” really means and how the grading system works. 

Sources: This guide is based on current medical literature and patient education resources (updated 2025), including expert input from MD Anderson Cancer Center, the American Association of Neurological Surgeons, and recent research findings in oncology. All medical information has been reviewed for accuracy and is intended for educational purposes. Always consult your physician for advice tailored to your situation. Stay hopeful and informed – science is making strides against astrocytomas and glioblastomas every day. 

Find Advanced Treatment on our Website under Study Finder

Download the Wetrials App to learn more.